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Background: We hypothesized that cognitive impairment and hemodynamic insta-
bility after infant cardiac surgery with cardiopulmonary bypass might be exacer-
bated by hemodilution.
Methods: In a single-center randomized trial with blinded assessment of outcomes,
we compared use of 2 hemodilution protocols during hypothermic cardiopulmonary
bypass with infant cardiac surgery. The primary perioperative end point was lowest
cardiac index in the first 24 hours postoperatively, and primary end points at age 1
year were scores on the Psychomotor Development Index and Mental Developmen-
tal Index of the Bayley Scales.
Results: Among 147 subjects, 74 were assigned to the lower-hematocrit strategy
(21.5%  2.9%, mean  SD at onset of low-flow bypass) and 73 to the higher-
hematocrit strategy (27.8%  3.2%). In intent-to-treat analyses the lower-hemat-
ocrit group had lower nadirs of cardiac index (P  .02), higher serum lactate levels
60 minutes after cardiopulmonary bypass (P  .03), and a greater percentage
increase in total body water on the first postoperative day (P .006). Blood product
use and adverse events were similar in the 2 groups. At age 1 year (113 children),
the lower-hematocrit group had worse scores on the Psychomotor Development
Index (81.9  15.7 vs 89.7  14.7, P  .008), as well as more Psychomotor
Development Index scores at least 2 SDs below the population mean (16/56 [29%]
vs 5/53 [9%], P .01). The groups had similar Mental Developmental Index scores
and findings on neurologic examination. Inferences using hematocrit as a continu-
ous variable were similar to those based on intent-to-treat analyses.
Conclusions: Hemodilution to a hematocrit level in wide use for cardiopulmonary
bypass and thought to be safe is associated with adverse perioperative and devel-
opmental outcomes in infants.
From the Departments of Cardiovascular
Surgery,a Cardiology,b Neurology,c Anes-
thesia,d and Pediatrics,e and the Clinical
Research Program,f Children’s Hospital
Boston, Boston, Mass; the Departments of
Surgery,g Pediatrics,h Anesthesia,i and
Neurology,j Harvard Medical School, Bos-
ton, Mass; and the Department of Biosta-
tistics,k Harvard School of Public Health,
Boston, Mass.
Supported by grants HL 063411 and RR
02172 from the National Institutes of
Health.
Read at the Eighty-second Annual Meeting
of The American Association for Thoracic
Surgery, Washington, DC, May 5-8, 2002.
Received for publication Oct 28, 2002; re-
visions requested Jan 21, 2003; revisions
received March 3, 2003; accepted for pub-
lication April 11, 2003.
Address for reprints: Richard A. Jonas,
MD, Department of Cardiovascular Sur-
gery, Children’s Hospital Boston, 300
Longwood Ave, Boston, MA 02115 (E-
mail: Richard.Jonas@tch.harvard.edu).
J Thorac Cardiovasc Surg 2003;126:
1765-74
Copyright © 2003 by The American Asso-
ciation for Thoracic Surgery
0022-5223/2003 $30.00  0
doi:10.1016/j.jtcvs.2003.04.003
Jonas et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 6 1765
CH
D
Cognitive impairment has been observedconsistently in adults after cardiopulmo-nary bypass (CPB)1 and is associated withthe number of microemboli detected duringcoronary artery bypass grafting.2 However,children, who are generally free of athero-
sclerosis, also can have neurocognitive sequelae after CPB.
In animal models magnetic resonance and near-infrared
spectroscopy suggest that brain injury might be caused by
hypoxic-ischemic injury as a result of currently recom-
mended protocols for hemodilution during CPB.3
Hemodilution during CPB was introduced in the 1950s
to decrease homologous blood use4 and has been thought to
improve microcirculatory flow.5 However, hemodilution
also might reduce perfusion pressure, which increases the
risk of an adverse neurologic outcome after CPB.6 Further-
more, hemodilution increases cerebral blood flow7 and
thereby might increase the microembolic load to the brain.
Finally, hemodilution reduces the oxygen carrying capacity
of blood; in combination with the leftward shift of oxyhe-
moglobin dissociation induced by hypothermia, which
might be further exacerbated by use of an alkaline pH
strategy, hemodilution might critically limit oxygen deliv-
ery to neurons and other cells.
Although experience with cardiovascular surgery in
adults refusing transfusion suggests that very low hemato-
crit levels can be tolerated,8 the optimal hematocrit level for
cerebral protection during hypothermic CPB has not been
defined. Published expert opinion9 has suggested that he-
matocrit levels of greater than 15% to 20% are safe during
CPB in adults, but no randomized trials in either adults or
children have examined the influence of hemodilution dur-
ing CPB on cognitive outcomes.
We hypothesized that greater hemodilution during hypo-
thermic CPB is associated with an increased risk of devel-
opmental impairment. To evaluate this hypothesis, we con-
ducted a prospective, randomized, single-center trial in
infants less than 9 months of age undergoing reparative
cardiac surgery with CPB. We compared hemodilution with
a hematocrit level of approximately 20% versus 30% with
respect to outcomes measured in the early postoperative
period and at age 1 year.
Methods
Enrollment of Patients
We enrolled patients between November 1996 and November
2000 at Children’s Hospital Boston. Eligibility criteria included
reparative cardiac surgery at less than 9 months of age for diag-
noses including D-transposition of the great arteries (D-TGA) with
intact ventricular septum or ventricular septal defect (VSD), te-
tralogy of Fallot (TOF), TOF with pulmonary atresia, truncus
arteriosus, VSD, or complete common atrioventricular canal de-
fect. Exclusion criteria included birth weight of less than 2.3 kg,
recognizable syndrome of congenital anomalies, associated extra-
cardiac anomalies of greater than minor severity (defined as those
that do not require treatment and have no effect on functional
status), previous cardiac surgery, or associated cardiovascular
anomalies requiring aortic arch reconstruction or additional open
surgical procedures before the planned developmental follow-up.
Of 209 eligible infants for whom informed consent was re-
quested, participation was declined in 57 (27%) cases. Of the 152
patients enrolled, 5 (3%) were excluded post hoc because the
operation was not performed as planned or because the patient was
discovered to have been ineligible after further clinical information
was obtained. The remaining 147 patients underwent reparative
surgical intervention according to the study protocol and constitute
the study population. Parental informed consent was obtained
according to institutional guidelines.
Study Design
Participating infants were randomly assigned to undergo hemodi-
lution to a hematocrit level of approximately 20% versus 30%,
with stratification according to surgeon and diagnostic group by
using blocked randomization. The method of support was assigned
immediately before the operation. Treatment assignment was di-
rectly observed by the perfusionists and study nurses. These indi-
viduals did not have access to interim study results. The surgeons,
anesthesiologists, cardiac intensivists, neurologists, and develop-
mental psychologists were blinded to patient treatment assignment.
Anesthesia and Perfusion Methods
After induction of anesthesia and placement of an arterial
catheter, surface cooling was begun with a low ambient room
temperature, a cooling mattress, and ice packs to the head. CPB
and core cooling were begun as soon as the venous and aortic
cannulae were in place. Patients had variable periods of full-
flow CPB at approximately 2.5 L · min1 · m2 when cooling
to various levels of hypothermia and usually during rewarming.
Some patients had periods of deep hypothermic circulatory
arrest, and most had at least one period of reduced-flow CPB
(eg, at approximately 0.75 L · min1 · m2 when at deep
hypothermia [ie, rectal temperature of 18°C]). After patient
randomization, hemodilution was achieved with whole blood
and PlasmaLyte A pH 7.4 (Baxter Healthcare Corp, Deerfield,
Ill). Standard perfusion calculations were used to determine the
volumes of the priming constituents, with the aim of obtaining
a hematocrit level of 20% or 30% at the time of onset of
low-flow CPB. Five patients did not have a period of low-flow
bypass. In intent-to-treat analyses these patients were included
in the group to which they were randomized; for continuous
analyses, we used the hematocrit level at the onset of rewarm-
ing. Hypothermic myocardial protection was provided by
means of infusion of oxygenated crystalloid cardioplegia (Pleg-
isol; Abbott Laboratories, North Chicago, Ill) usually as a
single dose of 20 mL/kg or a custom mix of 4 parts crystalloid
to 1 part blood (Baxter Compass, Edison, NJ). The pH-stat
strategy was used during core cooling, low-flow hypothermic
perfusion, and rewarming up to 30°C. Anesthetic management
and other aspects of perfusion on CPB were identical for both
groups. We used conventional ultrafiltration during CPB but not
modified ultrafiltration after CPB.
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Early Postoperative Data
During the first 24 hours after the operation, cardiac output was
determined at 3-hour intervals after removal of the aortic cross-
clamp by using the thermodilution technique. We measured serum
lactate 60 minutes after CPB. At 8 AM each day in the intensive
care unit, the study nurses recorded data on events, medications,
respiratory status, laboratory studies, fluid inputs and outputs, and
blood and blood product requirements. Bioelectric impedance was
measured preoperatively and on the first postoperative day to
estimate total body water.
Neurologic Examination
Neurologic examination was performed by pediatric neurologists
according to a uniform and predetermined protocol before the
operation and again at age 1 year. Abnormalities on neurologic
examination were classified according to specific type, including
head circumference, mental status, special senses, cranial nerve
motor function, and peripheral motor function. Patients were clas-
sified as having an abnormal neurologic examination result if any
summary item included a definite abnormality.
Developmental Evaluation
Of the 146 children alive at age 1 year, 20 were not invited to
return because of residence outside the United States (n  12),
parental inability to speak English (n  3), older age by the time
travel funds were procured (n  4), and diagnosis of chromosome
18 abnormality ascertained after the operation (n  1). Of the
remaining 126 families, 4 (3%) declined participation, 3 (2%) were
lost to follow-up, 2 (2%) cancelled their travel after the terrorist
attacks of September 11, 2001, and 4 (3%) declined in-person
evaluation but completed questionnaires. The remaining 113
(90%) children returned for in-person evaluation. One child was
tested only with a neurologic examination. Information on family
characteristics was obtained from interviews with the parents.
Two examiners administered the Bayley Scales of Infant De-
velopment,10 which yield scores on 2 indexes: the Psychomotor
Development Index (PDI) and the Mental Development Index
(MDI). We also calculated the proportion of children whose scores
were 85 or less or 70 or less (at least 1 or 2 SDs below the
population mean, respectively).
Statistical Analyses
The treatment groups were compared in intent-to-treat analyses.
Secondary analyses examined the effect of hematocrit level at the
onset of low-flow CPB as a continuous variable. All tests of
hypotheses and regression analyses of outcome variables were
adjusted for diagnostic group and grouped in the following way:
D-TGA (D-TGA/intact ventricular septum and D-TGA/VSD);
TOF (TOF, TOF with pulmonary atresia, and truncus arteriosus);
and VSD (VSD or common atrioventricular canal defect). We also
assessed potential interactions between hemodilution (treatment
assignment or hematocrit level as a continuous variable) and
diagnostic group on outcomes. On the basis of previous work, the
nadir of the cardiac index was the primary outcome variable in the
perioperative period. PDI and MDI scores were the primary out-
comes at age 1 year.
Outcomes included both continuous and categoric variables.
Linear regression and exact stratified Wilcoxon tests were used to
analyze continuous variables. Stratified exact tests and logistic
regression methods were used to analyze categoric variables. In
addition to diagnostic group, we performed analyses assessing
whether other potential predictor variables confounded or modified
the effects of hemodilution on primary and secondary end points.
These predictor variables included surgeon, sex, age at the time of
the operation, interval between the operation and developmental
examination, birth weight, maternal education, paternal education,
family social class, gestational age, Apgar score of 1, Apgar score
of 5, preoperative intubation, preoperative acidosis, calendar date
of the operation, preoperative neurologic examination results, type
of cardioplegia solution, lowest tympanic temperature, duration of
circulatory arrest, total bypass time, total support time, and indi-
vidual performing developmental testing. All P values are 2-tailed.
Assuming a sample size of 60 in each treatment group returning
for follow-up at age 1 year, our study had a power of 85% to detect
differences between treatment groups of 9 points (0.6 SD units)
after adjustment for simultaneous testing of the 2 primary out-
comes (PDI and MDI scores) at age 1 year by using the Bonferroni
method. Our National Heart, Lung, and Blood Institute–appointed
Data and Safety Monitoring Board terminated the study when 147
patients had been enrolled and 78 had returned for follow-up at age
1 year. At that time, statistical significance for early stopping was
reached with sequential analysis methods by using O’Brien-Flem-
ing stopping rules without multiple comparison adjustment and
Pocock stopping rules with or without multiple comparison adjust-
ment. The O’Brien-Fleming stopping rules with multiple compar-
ison adjustment did not quite reach statistical significance. In
considering all of the data, including differences between treat-
ment groups in postoperative outcomes, the Data and Safety Mon-
itoring Board stopped patient enrollment on December 2, 2000.
Results
Comparability of Treatment Groups
Among the 147 infants enrolled, 74 were assigned to the
lower-hematocrit group and 73 to the higher-hematocrit
group (Table 1). Treatment assignments were balanced
within the randomization strata of diagnostic group and
surgeon. The randomized infants within each diagnostic
group were similar at enrollment with regard to preoperative
variables that might influence outcomes, including preoper-
ative neurologic assessment.
Intraoperative Data
In accordance with the randomized assignments, the treat-
ment groups differed significantly with regard to hematocrit
level at the onset of low-flow CPB and at several other
intraoperative perfusion phases (Figure 1) but were similar
in durations of total CPB, circulatory arrest, low-flow by-
pass, total support (ie, total CPB time plus circulatory arrest
time), crossclamping, rates of cooling and rewarming, and
pH and CO2 levels before and during CPB (Table 1). The
proportion of subjects receiving each type of cardioplegia
(ie, Plegisol or the custom mix) was similar between treat-
ment groups; Plegisol was used in 18 (24%) of 74 and 16
(22%) of 73 subjects randomized to the lower- and higher-
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hematocrit strategies, respectively. Intraoperative blood
product use was similar between groups.
Postoperative Course
One (0.7%) infant randomized to the lower-hematocrit
group died within 1 month of the operation. Infants in the
lower-hematocrit group compared with those in the higher-
hematocrit group had lower nadirs of cardiac index over the
first postoperative 24 hours (2.8  1.1 vs. 3.1  1.1 L ·
min1 · m2, P  .02), as well as significantly lower
cardiac indexes at 6, 9, and 24 hours after removal of the
aortic crossclamp (Figure 2). Inotropic administration was
greater in the lower-hematocrit group at each 3-hour inter-
val, although the magnitude of the difference between
groups did not reach statistical significance at any of these
time points. The lower-hematocrit group also had higher
serum lactate levels 60 minutes after cessation of CPB (3.3
 1.9 vs 2.7  1.3 mmol/L, P  .03), as well as greater
percentage decreases in bioelectric impedance from the
preoperative period to the first postoperative day (38.2%
 16.5% vs 28.4%  20.3%, P  .006), reflecting a
greater percentage increase in total body water. In models
examining the effect of hematocrit level as a continuous
variable on perioperative outcomes, inferences were similar
to those based on the intent-to-treat analyses. Differences
between the hemodilution groups in durations of tracheal
intubation or time until hospital discharge did not reach
statistical significance (Table 2). Similarly, the incidence of
adverse events and the use of blood and blood products
were similar in the groups. No infant in either group had
definite clinical seizures.
Developmental Testing at Age 1 Year
The proportion of children in each treatment group who
returned for developmental follow-up was similar. Those
who returned for evaluation compared with those who did
not had parents with significantly higher educational levels
TABLE 1. Perioperative and operative characteristics ac-
cording to treatment group
Lower hematocrit
level (n  74),
mean  SD
Higher hematocrit
level (n  73),
mean  SD
Preoperative characteristics
Birth weight (kg) 3.37 .59 3.40 .61
Gestational age (wk) 39.0 1.5 39.0 1.7
Apgar score at 5 min 8.6 1.0 8.5 0.8
Age at operation, median
(range)
33 (1-259) 45 (1-269)
Sex (% male) 61 71
Race (% nonwhite) 23 16
Diagnosis group, n (%)
D-TGA 29 (39) 29 (40)
TOF/other 24 (32) 23 (32)
VSD/CAVC 21 (28) 21 (29)
Ever intubated (%) 46 36
Intubated at operation
(%)
23 22
Operative characteristics
Hematocrit level at onset
of low-flow bypass
21.5 2.9 27.8 3.2*
Crossclamp time 64 23 64 25
Total support time (min) 107 32 110 38
Total bypass time (min) 99 30 104 34
Low-flow bypass (min) 40 23 46 26
Duration of circulatory
arrest (min), median
(range)
0 (0-53) 0 (0-58)
None, n (%) 40 (54) 45 (62)
1-10 18 (24) 20 (27)
11-30 10 (14) 3 (4)
31-44 3 (4) 3 (4)
45 3 (4) 2 (3)
Fluid balance (mL), (in
minus out)
519 343 337 222†
Intraoperative blood
products (mL), median
(range)
168 (25-1383) 165 (30-480)
Preoperative neurologic
examination
Overall evaluation (%
abnormal)
65 68
CAVC, Common atrioventricular canal defect.
*P  .001 for difference between treatment groups determined by means
of linear regression, with adjustment for diagnosis group.
†P  .001 for difference between treatment groups determined by means
of linear regression, with adjustment for diagnosis group.
Figure 1. Plot of serial measurements of hematocrit levels ac-
cording to perfusion phases defined as follows: 1, after induction
of anesthesia; 2, administration of heparin; 3, 10 minutes after
onset of cooling; 4, onset of low-flow bypass; 5, 10 minutes after
onset of rewarming; 6, start of warm flow; and 7, 60 minutes off
bypass. Values are depicted as the mean  1 SD. After adjust-
ment for diagnostic group, statistically significant differences
were found for phases 3, 4, 5, and 7.
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and were more likely to be white but were otherwise similar
in perioperative characteristics. No subjects underwent car-
diac reoperation before returning for developmental testing.
In 113 children returning at age 1 year, the lower-hema-
tocrit group had worse PDI scores (81.9  15.7 vs 89.7 
14.7, P  .008; Figure 3) and more PDI scores at least 2
SDs less than the population mean (16/56 [29%] vs 5/53
[9%], P  .01; Table 3). After stepwise linear regression
modeling, adjusting for diagnostic group, higher PDI scores
were related to the absence of preoperative endotracheal
intubation (P  .03), higher birth weight (P  .03), lower
social class (P  .01), and assignment to the higher-hema-
tocrit group (P  .01). Among these factors, hematocrit
treatment assignment was the single most important predic-
tor of PDI scores in terms of statistical significance and
improvement in proportion of variance explained (6.3%).
When hematocrit level at the onset of low-flow CPB was
analyzed as a continuous variable, adjusting for diagnostic
group, lower hematocrit levels were associated with lower
PDI scores (P  .02, adjusting for diagnostic group; Figure
4). A change in hematocrit level from 20% to 30% was
associated with an 8.2-point increase in PDI score, greater
than a half SD difference. After further adjustment in step-
wise linear regression for preoperative endotracheal intuba-
tion, birth weight, and social class, hematocrit level at the
onset of low-flow bypass remained a significant predictor of
PDI score (P  .03).
Mean scores on the MDI were similar in the lower- and
higher-hematocrit groups (92.1  14.5 vs 94.4  11.0,
respectively; Figure 3). A greater proportion of children in
the lower-hematocrit group compared with the higher-he-
matocrit group had MDI scores more than 1 SD less than the
mean (18/59 [31%] vs 6/53 [11%], P  .02). The treatment
groups did not differ significantly in the percentage of
children with MDI scores more than 2 SDs less than the
mean, but our power to detect differences was extremely
limited. Significant predictors of higher MDI scores in-
cluded female sex (P .02), higher birth weight (P .007),
and higher social class (P  .005). In multiple regression
models hematocrit levels at the onset of low-flow CPB were
not significantly associated with MDI scores.
Abnormal neurologic examination results were common
but did not differ in frequency between the lower- and
higher-hematocrit groups (60% vs 58%, respectively). Sim-
ilarly, no treatment group differences were found with re-
spect to specific types of abnormalities (Table 4). Common
findings in both groups were abnormal muscle tone (usually
decreased) and abnormal oromotor function.
Figure 2. Plot of serial measurements of cardiac index, as deter-
mined by using the thermodilution technique. Values are depicted
as the mean  1 SD. Not all patients had measurements in all
time periods; however, only those with measurements in at least
4 time periods were included in analyses. After adjustment for
diagnostic group, statistically significant differences were found
at 6, 9, and 24 hours after removal of the aortic crossclamp.
TABLE 2. Postoperative course according to treatment
group P value*
Variable
Lower hematocrit
level (n  74)
Higher hematocrit
level (n  73)
P
value*
Lowest cardiac
index (L · min1 ·
m2)
2.8 1.1 3.1 1.1 .02
Lactate 60 min after
bypass
3.3 1.9 2.7 1.3 .03
Resistance (%
change from
preoperative to
postoperative day
1)
38.2 16.5 28.4 20.3 .006
Postoperative blood
products (total)
(mL), median
(range)
126 (0, 3551) 120 (0, 1874) .58
Days intubated,
median
(interquartile
range)
1.9 (1.0, 2.9) 1.5 (1.1, 2.8) .35†
Days in ICU,
median
(interquartile
range)
4 (2-5) 3 (2-4) .15†
Days in hospital,
median
(interquartile
range)
7 (5-9) 6 (5-9) .39†
ICU, Intensive care unit.
*P values determined by means of linear regression, are for differences
between treatment groups, with adjustment for diagnosis group.
†P values determined by means of Wilcoxon rank sum tests, are for
differences between treatment groups, with adjustment for diagnosis
group.
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Influence of Other Surgical Variables
We explored whether the effect of hematocrit strategy on
study outcome was influenced by perfusion variables, in-
cluding type of cardioplegia, use and duration of total cir-
culatory arrest, duration of low-flow bypass, or degree of
hypothermia. There was a significant interaction between
treatment assignment and type of cardioplegia for nadir of
cardiac index (P  .01) and percentage change in bioim-
pedance on postoperative day 1 (P  .03), with treatment
group differences being slightly larger among those who
received Plegisol. However, with either cardioplegia solu-
tion, assignment to the higher-hematocrit strategy provided
better outcomes. There was no significant interaction be-
tween treatment assignment and type of cardioplegia with
respect to lactate level 60 minutes after cessation of bypass,
PDI score, or MDI score. Similarly, we found no significant
interaction between either treatment assignment or hemat-
ocrit level as a continuous variable and the other perfusion
variables in their effects on early postoperative outcomes or
outcomes at age 1 year. In addition, adjustment for surgeon
or a surgeon-by-treatment-group interaction term did not
alter the study results.
There was no interaction of diagnosis group and either
treatment assignment or hematocrit level measured as a
continuous variable on any outcome measured postopera-
tively or at age 1 year.
Discussion
Hemodilution is currently used almost universally for CPB,
but the minimum safe hematocrit level remains poorly de-
fined. In our randomized trial we found that children as-
signed to the lower-hematocrit group had worse periopera-
tive outcomes. In developmental follow-up the lower-
hematocrit group had worse scores on the PDI component
of the Bayley Scales of Infant Development, as well as a
significantly greater proportion with PDI scores more than 2
SDs less than the population mean. The sensitivity of the
PDI score to hypoxic-ischemic injury in infancy is likely to
reflect the selective vulnerability of cerebral white matter.11
Inferences using hematocrit level as a continuous variable
were similar to those based on intent-to-treat analyses. Ex-
posure to homologous blood transfusion was the same for
both groups.
Studies in animal models of hemodilution during CPB
have shown conflicting results. In a canine model systemic
oxygen consumption was maintained on CPB until the
hematocrit level was diluted to less than 20%,12 but other
studies13,14 reported that a critical hematocrit level of 9% to
14% maintains adequate oxygen delivery during normother-
mic CPB. In piglets hemodilution to a hematocrit level of
10% during hypothermic CPB caused inadequate oxygen
delivery during early cooling, and a higher hematocrit level
was associated with improved cerebral recovery after deep
hypothermic circulatory arrest.3 In addition, intravital mi-
Figure 4. Scatterplot of PDI scores at age 1 year as a function of
hematocrit level at the onset of low-flow bypass. The solid line
was derived by means of linear regression of the data, and the
dashed lines delimit the 95% confidence interval. Diagnosis was
not predictive of this outcome. The linear regression P value
shown is for the effect of hematocrit at the onset of low-flow
bypass on outcome, with adjustment for diagnostic group.
Figure 3. Box plots of PDI and MDI scores at age 1 year accord-
ing to hematocrit group (lower hematocrit level vs higher hemat-
ocrit level at the onset of low-flow bypass). The solid bar within
the box represents the median value, the upper boundary of the
box represents the 75th percentile, and the lower boundary of the
box represents the 25th percentile. The vertical lines extend to
the 10th and 90th percentiles, with more extreme observations
plotted as circles. The linear regression P values shown are for
the effect of hematocrit group on outcome, with adjustment for
diagnostic group.
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croscopy in a piglet model15 demonstrated that a higher
hematocrit level during cooling does not impair cerebral
microcirculation.
Several studies in adults undergoing cardiac surgery
have suggested that low hematocrit values are associated
with worse neurologic outcome,16,17 whereas others have
found no effect.18,19 Newman and colleagues1 recently re-
ported an incidence of cognitive decline of 53% at hospital
discharge and 42% at 5 years but did not examine whether
the lowest hematocrit level on CPB was a risk factor.
Similarly, previous pediatric studies have not examined
hemodilution as a potential cause of adverse neurocognitive
outcome after CPB. In a randomized trial of bypass strate-
gies in children, Kurth and associates20 found that cerebro-
vascular oxygen extraction diminished postoperatively in
the group randomized to hypothermic low-hematocrit by-
pass; however, postoperative neurocognitive function was
not assessed.
We found decreased cardiac index and higher serum
lactate levels early postoperatively among those with lower
hematocrit levels on CPB. Although earlier small studies
suggested a wide range of tolerable hematocrit levels,21,22 2
recent large studies in adults have supported the hypothesis
that lower hematocrit levels during CPB are associated with
adverse hemodynamic outcome.23,24 The association of low
cardiac output with hemodilution might be explained by
reduced endocardial blood flow,25 thereby decreasing cor-
onary perfusion and myocardial oxygen delivery. In addi-
tion, reduced hemodilution could preserve higher serum
oncotic pressure, improving microcirculatory flow and de-
creasing myocardial edema.
Our data should be viewed in light of certain limitations.
Infant neurocognitive tests have good concurrent validity
but limited predictive validity in the normal population26;
however, the predictive validity of the Bayley Scales tends
to be considerably higher in samples of at-risk infants.27
The relative deficits of children assigned to the lower-
hematocrit group were most prominent in motor function,
but assessments at older ages might reveal treatment effects
in other domains, such as language or visual-motor integra-
tion, that are not easily tested in very young children.
Children with congenital heart disease might have multiple
risk factors for neurologic impairment. To determine the
effects of the 2 hemodilution strategies on development
using the smallest possible number of subjects, we studied
a patient population in whom potential competing risk fac-
tors (eg, other anomalies and low birth weight) were mini-
mal at a single center. Finally, assignment to the higher-
hematocrit strategy provided better outcomes over a range
of perfusion variables, suggesting that our findings can
likely be generalized. However, we cannot exclude the
possibility that differences in intraoperative conduct at other
institutions could influence the magnitude of effect of he-
matocrit levels on postoperative hemodynamic or develop-
mental status. Finally, although hemodilution to 20% pro-
duced outcomes inferior to those at 25% and greater, we
could not determine a specific target hematocrit level of
greater than 25% that was optimal.
TABLE 3. Scores on developmental tests according to
treatment group
Test
Lower hematocrit
level (n  59),
mean  SD
Higher hematocrit
level (n  53),
mean  SD
P
value*
Psychomotor
Development Index
81.9 15.7 89.7 14.7 .008
Mental Development
Index
92.1 14.5 94.4 11.0 .36
Psychomotor
Development
Index, no. with low
score/total no. (%)
85 30/56 (54) 22/53 (42) .18
70 16/56 (29) 5/53 (9) .01
Mental Development
Index, no. with low
score/total no. (%)
85 18/59 (31) 6/53 (11) .02
70 4/59 (7) 2/53 (4) .68
*P values are for differences between treatment groups, with adjustment
for diagnosis. P values were determined by means of linear regression for
continuous outcome variables and stratified exact tests for dichotomous
outcome variables.
TABLE 4. Neurologic abnormalities according to treatment
group
Variable
Lower hematocrit
level (n  55), no.
with abnormality/
total no. (%)
Higher hematocrit
level (n  48), no.
with abnormality/
total no. (%)
P
value*
Overall abnormal
examination result
33/55 (60) 28/48 (58) .84
Head circumference .62
Microcephaly† 3/55 (5 ) 0/48
Macrocephaly‡ 0/55 1/48 (2 )
Special senses (visual
or auditory)
2/54 (4 ) 2/48 (4 ) 1.00
Cranial nerves
(oculomotor, facial
oromotor function)
23/54 (43) 18/46 (39) .84
Motor function
(strength, tone,
reflexes)
18/55 (33) 14/47 (30) .83
*P values, determined by stratified exact tests, are for differences between
treatment groups with adjustment for diagnosis group.
†Microcephaly is defined as a head circumference less than 2 SDs below
the mean for age.
‡Macrocephaly is defined as a head circuference greater than 2 SDs
above the mean for age.
Jonas et al Surgery for Congenital Heart Disease
The Journal of Thoracic and Cardiovascular Surgery ● Volume 126, Number 6 1771
CH
D
In summary, hemodilution to a hematocrit level currently
in wide use and thought to be safe during hypothermic
CPB28 is associated with adverse perioperative and devel-
opmental outcomes in infants. Indeed, the magnitude of this
effect on outcomes at age 1 year (approximately 0.5 SD) is
considerably greater than that associated with low-level lead
poisoning29 and approximately the same as that associated
with very low birth weight (1500 g).30 Use of a higher
hematocrit level during hypothermic CPB was not associ-
ated with greater use of blood products. Future randomized
studies are needed to refine the optimum hematocrit level
during infant cardiac surgery and to investigate whether
hemodilution contributes to the cognitive decline observed
in adults after CPB.
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Discussion
Dr William A. Baumgartner (Baltimore, Md). I would like to
congratulate Dr Jonas and his colleagues on an extremely well-
presented randomized prospective study of the influence of he-
modilution in infants undergoing hypothermic CPB, the results of
which could have significant influences on the refinement of CPB
in the specialty of congenital heart surgery, as well as potentially
in its application to adults undergoing CPB.
The authors have demonstrated the negative effect of a lower
hematocrit level on perioperative outcomes, including a lower
cardiac index, a higher serum lactate level, and a greater increase
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in total body water. Of significant importance is the demonstration
that 1-year neurologic evaluation demonstrated significantly worse
scores in patients in whom hematocrit levels averaged 21.5%
versus 27.8%.
In addition to the neurologic decline associated with infants
undergoing CPB with a low hematocrit level, the authors demon-
strated worse perioperative outcomes. These pediatric findings do
have a corollary within adult cardiac surgical populations. In a
recent article from the Northern New England Cardiovascular
Disease Study Group, DeFoe and associates performed a retro-
spective review of a consecutive series of 6980 patients undergo-
ing isolated coronary artery bypass graft surgery. After adjustment
for preoperative differences in patient and disease characteristics,
the lowest hematocrit level during CPB was significantly associ-
ated with increased risk of in-hospital mortality and postoperative
placement of an intra-aortic balloon pump.
The other major adult inference in this particular study is based
on their study populations of infants. Microembolism, as you heard
from Dr Jonas, is thought to be the most plausible explanation for
neurocognitive decline seen in adults. Infants, as he mentioned, are
generally free of atherosclerosis and therefore would be at signif-
icantly less risk for microembolism, suggesting that the neurologic
decline seen in adults might be significantly influenced by other
nonatherosclerotic variables, including a lower hematocrit level.
This work from the Children’s Hospital in Boston is a classic
translational study built on their experimental research work.
These results have direct clinical application to children undergo-
ing hypothermic CPB and will stimulate those of us interested in
neurocognitive decline in adults to examine what would appear to
be a significant CPB variable.
I have a couple of questions for Dr Jonas. Because neurologic
sequelae can be attributed to many factors, including the time of
both cooling and rewarming, especially when deep hypothermic
circulatory arrest is used, would you please comment on the
technique used in these infant operations?
My second question concerns the children who did not return
for their neurologic testing. Of the 146 children who were alive at
1 year, 33 were not evaluated for a variety of reasons. Of this
group of patients, how were they divided on the basis of the 2
hematocrit groups, and did you see any significant differences in
perioperative outcome in this select cohort of children?
In summary, the authors’ results demonstrate for the first time
that neurocognitive decline in infants is associated with lower
hematocrit levels during hypothermic CPB and suggest that this
might be a significant variable in the decline of neurocognitive
outcomes in adults.
Dr Jonas. Thank you, Dr Baumgartner. Our group in Boston
has admired for many years the outstanding work that you and
your group have undertaken at Hopkins looking at cerebral pro-
tection in this same area.
In answer to your question regarding our specific technique of
hypothermic CPB in infants, there were 5 surgeons who were part
of this particular trial. We did use different methods of venous
cannulation, and there were no specifications as to which temper-
ature one should cool to, for example. However, patients were
randomized according to surgeon, and there was no influence of
surgeon on the hematocrit outcome.
My own technique for hypothermic bypass for patients under-
going an arterial switch procedure or repair of tetralogy is to use a
single venous cannula and to rely on competence of the tricuspid
valve to avoid air entrainment. In the past we used to use a very
cold prime in going on to bypass. We now believe that that is a
mistake. We think that it is important to begin with a prime that is
relatively warm, at least 30°C and possibly warmer. This is be-
cause of the effect that hypothermia has in shifting oxyhemoglobin
dissociation to the left, which I think is one of the fundamental
problems that we are seeing here, that it is the combination of
hypothermia plus the alkaline pH that results if one uses the
alpha-stat strategy in combination with hemodilution that critically
limits oxygen delivery in the early phase of cooling before circu-
latory arrest or before reduced-flow bypass or during just regular
bypass itself. Therefore the pH-stat strategy, we believe, is also a
very important part of the technique and is now routinely used at
Children’s Hospital in Boston. Incidentally, we have noted that in
a recent survey the pH-stat strategy is now used in approximately
60% of programs doing pediatric cardiac surgery. I cool in this
fashion over a period generally in the region of 15 to 20 minutes.
We think that the old method of very rapid cooling of perhaps 5 to
10 minutes, which is the way we used to do it 15 or 20 years ago,
is no longer appropriate, although it is difficult to put a specific
number on cooling time if one is going to deep hypothermia, for
which we generally use a rectal temperature of less than 18°C,
which usually corresponds to a tympanic membrane temperature
of 15°C.
If we use reduced flow bypass at deep hypothermia, we would
go to a flow rate of 50 mL · kg1 · min1. In an average-size
neonate that corresponds to a flow index of about 0.75 L · min1
· m2.
We do not believe that the rewarming phase is as critical as the
cooling phase. All of our laboratory studies and all of our clinical
studies—this is our third large prospective trial—have pointed at
the cooling phase as being the critical time when injury occurs.
This is the time when the brain is still warm and has a high
metabolic rate, and this is when you suddenly limit oxygen deliv-
ery through the factors that I mentioned. But generally if rewarm-
ing from deep hypothermia, we would rewarm over approximately
30 minutes back to a rectal temperature of 35°C. We do think that
excessive rewarming is a mistake. And the temperature in the first
24 hours postoperatively should also be very carefully controlled.
I think that the fever that one sees from bypass or from any other
cause can be an important contributor to exacerbating the neuro-
logic injury that might otherwise result from the factors that we
have talked about to this point.
Regarding your second question, there were 146 children who
were alive at 1 year, and of these, we actually did not invite 20 to
return. This was because 12 of them lived overseas, 3 of them had
parents who could not speak English, and we did not have travel
funds available for 4 patients. We were paying for the majority of
these patients to travel some distance. Of the 126 families who
were invited to return, 4 declined participation, 3 were lost to
follow-up, and 2 cancelled their travel, which was planned imme-
diately after September 11th. Four families declined in-person
evaluation but completed questionnaires.
The return rates for the 2 randomization groups were similar,
and we did undertake careful comparisons of the 113 patients who
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returned with the 34 patients who did not and found no statistically
significant differences in treatment assignment or in any perioper-
ative outcome. However, the children who returned were more
likely to be white and to have higher maternal or paternal educa-
tion, and therefore we subsequently adjusted for race and parental
education in analysis of the 1-year follow-up data and did not find
that this made any appreciable difference.
Again, I should emphasize that the majority of patients who did
not come back were actually not invited to come back and were not
self-selected, and therefore hopefully we did not introduce bias in
this way.
In summary, we agree with you that patient selection is an
important issue that needs to be carefully examined in follow-up
studies of developmental outcome. However, we believe it is
unlikely that patient selection had a significant effect on the results
of our trial.
Dr Vaughn A. Starnes (Los Angeles, Calif). I enjoyed your
article very much, and again, it is a major contribution to making
bypass in children safe.
When it comes to regional distribution of blood flow, and
looking at your groups, particularly in the transposition group,
where we can have major collaterals and flow-distribution issues,
was that controlled for just with intergroup numbers being the
same of transposing each of the group or equalization of that?
Dr Jonas. We did not enroll patients who had TOF with
macroscopic collateral vessels, and I am not aware of any patients
in the series who had collaterals of a sufficient size, for example,
to warrant subsequent coil embolization. But we did not specifi-
cally attempt to measure collateral return coming through diffuse
collateralization. The majority of these patients are quite young, so
that hopefully there would not have been development of collat-
erals over time resulting from chronic cyanosis.
We do think that collaterals are particularly important in those
patients who have macroscopic collaterals. It was those sort of
patients in whom we had an epidemic of choreoathetosis in the
mid-1980s, when we shifted to the alpha-stat strategy. Therefore I
think the pH strategy is particularly important in patients who have
large collaterals, and I think the hemodilution effect would likely
be magnified in those patients, but we did not specifically measure
that or look for that.
Dr Charles D. Fraser, Jr (Houston, Tex). I was wondering if
you thought in an individual patient that an ideal hematocrit level
would be able to be predicted on the basis of intraoperative
variables? In other words, how do you practically decide what
would be the ideal hematocrit level during bypass? Also, could you
just speculate on how a lower hematocrit level during CPB neg-
atively affects the cardiac index in the postoperative period?
Dr Jonas. If I can take the second question first, in looking
through the literature I discovered a very interesting article by our
current editor of the Journal. Dr Wechsler has looked at the
question of myocardial protection related to hematocrit level. I do
not know whether Dr Wechsler would like to comment, but he
looked at distribution of blood flow and found that there was
reduced flow to the subendocardium with hemodilution in a situ-
ation in which there were coronary stenoses in an animal model. I
think it is distribution away from watershed areas that is probably
important in terms of the cerebral protection in adults. Whether
and how that has an effect in children who do not have cerebral or
carotid stenoses is unclear to me. This was a surprise finding of the
study. We certainly had not hypothesized that hematocrit level
would have an influence on myocardial protection.
I would suggest that studies that use measurement of postop-
erative cardiac output over the first 24 hours are using a particu-
larly effective tool to measure myocardial protection. It is inter-
esting how rarely postoperative cardiac output has been used over
the years. Therefore I do not have any further speculation other
than there is some evidence of redistribution of flow away from the
subendocardium with anemia.
Regarding the ideal hematocrit level for an individual patient,
the unknown question that remains at this point is this: if 27% is
better than 21%, is 35% better than 27%? In fact, we are currently
enrolling patients in a trial in which we are randomizing patients
between 35% and 25%. There is clearly an interaction between
factors, such as the flow rate and the pH, and the ideal hematocrit
level. In our laboratory model right now we are examining exactly
that question because the fact is that up until now we have really
flown blind; it is like flying an aircraft in fog without instruments.
We choose temperatures, flow rates, hematocrit levels, and pH
without any real understanding as to how effectively we are
delivering oxygen to cerebral neurons, but hopefully within an-
other 2 to 3 years we will have more information regarding ideal
hematocrit levels for the specific conditions of temperature, flow
rate, and pH for an individual patient.
Dr Soon J. Park (Minneapolis, Minn). Dr Jonas, this is a
wonderful study. I have a question. In the adult population, at least
in our institution, we are using systemic venous oxygen saturation
(SVO2) monitoring extensively during the period of cooling and
rewarming. Have you used these data in this children’s study, and
then, would you modify your practice on the basis of SVO2? For
example, patients with a low hematocrit level, did they have
substantially lower SVO2 values during the phase of operation
compared with children in the higher-hematocrit group?
Dr Jonas. I think you raise a very important point. When I say
we have flown blind without instruments, I think we have been
seriously misled by SVO2. That has really, in a sense, been our gold
standard, and I firmly believe that under conditions of hypothermia
and with an alkaline pH resulting from use of the alpha-stat
strategy that SVO2 can be extremely misleading. I am sure you have
noted that immediately on commencing rewarming you see a
decrease in SVO2. Why does that happen? The brain and the body
have not yet had an opportunity to rewarm and to increase their
metabolic rate and oxygen requirement, and yet there is an almost
immediate decrease in venous oxygen saturation. I would suggest
that this phenomenon demonstrates the fact that there has been
inadequate oxygen delivery related to the effects I have been
talking about and suggest that an oxygen debt has been incurred.
Therefore when you and me and our perfusionists are reassured
by seeing an SVO2 of 95% or 100%, I think we are being falsely
reassured. I think in fact that there might be an oxygen debt being
incurred in spite of high venous oxygen saturations. In this study
we did not place monitoring catheters to monitor SVO2 postoper-
atively, but we did, of course, use continuous on-line monitoring of
SVO2 during bypass.
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